共 50 条
- [42] Importance of Risk Factors for Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified as High-Risk in Guidelines for Myeloid Growth Factor Use JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (08): : 979 - +
- [46] Real-World Impact of Prophylactic Growth Factor Use on Timing of Febrile Neutropenia and Infection After High-Risk Chemotherapy JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (09): : 945 - +